Injection Pen Market Size is estimated to grow at a CAGR of 6.0% during the forecast period
During the projected period of 2022–2030, the global
injection pen market is expected to develop at a compound
annual growth rate (CAGR) of 6.0%.
Insulin pens, sometimes referred to as injection pens, are
advanced prefilled syringes that have been carefully created for
self-administration of drug delivery in a variety of therapies and chronic
illnesses. Small doses of hormones or
medications are injected into patients' bodies using these pens to treat
specific disorders. These pens efficiently replace conventional injection
methods for treating a range of medical diseases since they are portable, more
precise, straightforward, user-friendly, and handy in their delivery.
Request
For Free Sample Pages @ https://www.xresearch.biz/request-sample-pages/injection-pen-market
Growth Drivers:
The primary factors propelling this market's expansion are
the rising prevalence of conditions like diabetes and arthritis among people
worldwide, the surge in demand for safer and more advanced drug delivery
devices, the rising geriatric population, the technological advancements in
injection pens, the rising number of regulatory approvals, the favorable
reimbursement environment in developed economies, and the rising use of home
healthcare.
Additionally, as the number of people using injection pens
to treat insulin-related issues increases around the world, the manufacturers
of injection pen are seen to be placing major emphasis on improving the design
characteristics of the injection pens, the ease of injection, the use of the
insulin-dose setting dial, the simplicity of cartilage replacement, and the
prominence of audio clicks. The growth of the worldwide
injection market is predicted to be greatly aided by this
aspect throughout the projected period.
Nevertheless, factors like a lack of knowledge about the
use of injection pens, the high cost of injection pens, and the rising
preference for alternative drug delivery methods because of a fear of syringes
are anticipated to significantly restrain the growth of the global injection
pen market during the forecast period.
Injection Pen Market Segmentation:
By Type:
· Disposable
Injection Pens
· Reusable
Injection Pens
By End User:
· Home
Care
· Hospital
& Clinics
· Others
By Therapy:
· Diabetes
o Insulin
o GLP-1
· Growth
Hormone Therapy
· Fertility
· Osteoporosis
· Other
Therapies
By Dosage:
· Fixed
· Variable
By Region:
· North
America
· Europe
· Asia
Pacific
· Latin
America
· Middle
East and Africa
Key Companies in Injection Pen Market:
· AstraZeneca
· Novartis
· Roche
Holding AG
· Medtronic
· Sanofi
· Becton
Dickinson and Company
· Eli
Lilly Company
· Novo
Nordisk
· F.
Hoffman-La Roche
· Mylan
N.V
· Sandoz
Inc
· Merck
Group
· Haselmeier
· Gerresheimer
AG
· Ypsomed
· Pfizer
Inc.
· Owen
Mumford Ltd
· GlaxoSmithKline
plc
· Other
Players
For
More Information about this Report @ https://www.xresearch.biz/shop/injection-pen-market
About
Us: -
xResearch is a market research and consulting organization
that uses unique data, expert analysis, and new technologies to create trusted
intelligence on industries. Our research is focused on delivering an informed
and impartial view on essential market data of industry, and it is primarily
driven by an in-depth study covering the following parameters: Market Sizing and
Forecasting, Market Segmentation, Competitive Analysis, Strategic Assessment
and Business Modelling.
Contact:
Company Name: xResearch
Contact Person: James Lin
Email: sales@xresearch.biz
Phone: +1 718-618-4545
Comments
Post a Comment